Cover Image
市場調查報告書

臨床化學分析設備:醫療設備的開發平台評估

Clinical Chemistry Analyzers - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 348460
出版日期 內容資訊 英文 166 Pages
訂單完成後即時交付
價格
Back to Top
臨床化學分析設備:醫療設備的開發平台評估 Clinical Chemistry Analyzers - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年11月14日 內容資訊: 英文 166 Pages
簡介

本報告提供臨床化學分析設備的開發中產品調查分析,以各開發階段比較分析為焦點,提供您正在開發開發中產品的主要企業,包含進行中的臨床試驗相關資訊等系統性資訊。

第1章 目錄

第2章 簡介

  • 臨床化學分析設備概要

第3章 開發中的產品

  • 臨床化學分析設備 - 開發中產品:各開發階段
  • 臨床化學分析設備 - 開發中產品:各市場區隔
  • 臨床化學分析設備 - 開發中產品:各地區
  • 臨床化學分析設備 - 開發中產品:法規別
  • 臨床化學分析設備 - 開發中產品:核准預定日別
  • 臨床化學分析設備 - 進行中的臨床試驗

第4章 臨床化學分析設備 - 正在開發的開發中產品:各企業

  • 臨床化學分析設備企業 - 開發中產品:各開發階段
  • 臨床化學分析設備 - 開發中產品:各開發階段

第5章 臨床化學分析設備企業與產品概要

  • Abingdon Health Ltd
  • Agenix Limited
  • Analyticon Biotechnologies AG
  • Atonomics A/S
  • Attophotonics Biosciences GmbH
  • Aviv Biomedical, Inc.
  • Beacon Biotechnology
  • Becton, Dickinson and
  • Bio-Alternative Medical Devices Ltd
  • bioMerieux S.A.
  • CAIR Technologies Inc.
  • Clinical Sensors, Inc.
  • Curetis AG
  • Daxor Corporation
  • EMERGENT DETECTION INC
  • Exact Sciences Corporation
  • GenPrime Incorporated
  • Hansjorg Wyss Institute for Biologically Inspired Engineering
  • Holomic LLC
  • Illumina, Inc.
  • i-SENS, Inc.
  • IV Diagnostics, Inc.
  • National Institute of Biomedical Imaging and Bioengineering
  • NeuMoDx Molecular, Inc
  • Nova Biomedical Corporation
  • Renishaw Plc
  • Rheonix, Inc.
  • Roche Diagnostics International Ltd.
  • Samsung Electronics Co., Ltd.
  • Sekisui Diagnostics, LLC.
  • SenGenix, Inc.
  • Shenzhen Genius Electronics Co., Ltd.
  • The Hong Kong University of Science and Technology
  • Thermal Gradient, Inc.
  • Verifica-BG, Inc.

第6章 臨床化學分析設備 - 最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0252EPD

GlobalData's Medical Devices sector report, "Clinical Chemistry Analyzers - Medical Devices Pipeline Assessment, 2016" provides an overview of Clinical Chemistry Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Clinical Chemistry Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Clinical Chemistry Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Clinical Chemistry Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Clinical Chemistry Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Clinical Chemistry Analyzers Overview

3. Products under Development

  • 3.1. Clinical Chemistry Analyzers - Pipeline Products by Stage of Development
  • 3.2. Clinical Chemistry Analyzers - Pipeline Products by Segment
  • 3.3. Clinical Chemistry Analyzers - Pipeline Products by Territory
  • 3.4. Clinical Chemistry Analyzers - Pipeline Products by Regulatory Path
  • 3.5. Clinical Chemistry Analyzers - Pipeline Products by Estimated Approval Date

4. Clinical Chemistry Analyzers - Pipeline Products under Development by Companies

  • 4.1. Clinical Chemistry Analyzers Companies - Pipeline Products by Stage of Development
  • 4.2. Clinical Chemistry Analyzers - Pipeline Products by Stage of Development

5. Clinical Chemistry Analyzers Companies and Product Overview

  • 5.1. Analyticon Biotechnologies AG Company Overview
    • 5.1.1. Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Ativa Medical Inc. Company Overview
    • 5.2.1. Ativa Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Aviv Biomedical, Inc. Company Overview
    • 5.3.1. Aviv Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Beacon Biotechnology Company Overview
    • 5.4.1. Beacon Biotechnology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Curetis N.V. Company Overview
    • 5.5.1. Curetis N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Daxor Corporation Company Overview
    • 5.6.1. Daxor Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. DiaSys Diagnostic Systems GmbH Company Overview
    • 5.7.1. DiaSys Diagnostic Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. EMERGENT DETECTION INC Company Overview
    • 5.8.1. EMERGENT DETECTION INC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview
    • 5.9.1. Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Illumina, Inc. Company Overview
    • 5.10.1. Illumina, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Intelligent Fingerprinting Ltd Company Overview
    • 5.11.1. Intelligent Fingerprinting Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. I-Sens Inc. Company Overview
    • 5.12.1. I-Sens Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. MyCartis NV Company Overview
    • 5.13.1. MyCartis NV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. NanoIVD Inc (Inactive) Company Overview
    • 5.14.1. NanoIVD Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. National Institute of Biomedical Imaging and Bioengineering Company Overview
    • 5.15.1. National Institute of Biomedical Imaging and Bioengineering Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. NeuMoDx Molecular, Inc Company Overview
    • 5.16.1. NeuMoDx Molecular, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. OPKO Health, Inc. Company Overview
    • 5.17.1. OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. OptiCul Diagnostics Ltd. Company Overview
    • 5.18.1. OptiCul Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Renishaw Plc Company Overview
    • 5.19.1. Renishaw Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Rheonix, Inc. Company Overview
    • 5.20.1. Rheonix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Samsung Electronics Co., Ltd. Company Overview
    • 5.21.1. Samsung Electronics Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Sekisui Diagnostics, LLC. Company Overview
    • 5.22.1. Sekisui Diagnostics, LLC. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Smiths Detection Group Limited Company Overview
    • 5.23.1. Smiths Detection Group Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. The Hong Kong University of Science and Technology Company Overview
    • 5.24.1. The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Theranos Inc Company Overview
    • 5.25.1. Theranos Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Thermal Gradient, Inc. Company Overview
    • 5.26.1. Thermal Gradient, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Clinical Chemistry Analyzers- Recent Developments

  • 6.1. Nov 10, 2016: Siemens Healthcare Plans IPO
  • 6.2. Nov 08, 2016: Exact Sciences Appoints Jeff Elliott Chief Financial Officer
  • 6.3. Nov 07, 2016: OPKO Health Reports Third Quarter Financial and Operating Results
  • 6.4. Nov 07, 2016: PerkinElmer Announces Financial Results for the Third Quarter of 2016
  • 6.5. Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results
  • 6.6. Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance
  • 6.7. Nov 02, 2016: QIAGEN Reports Results for Third Quarter and First Nine Months of 2016
  • 6.8. Nov 02, 2016: Lak Ananth to head new next47 startup unit
  • 6.9. Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent
  • 6.10. Nov 01, 2016: Illumina Reports Full Financial Results for Third Quarter of Fiscal Year 2016
  • 6.11. Nov 01, 2016: Asuragen Launches QuantideX NGS RNA Lung Cancer Kit
  • 6.12. Nov 01, 2016: IDEXX Laboratories Announces Third Quarter Results
  • 6.13. Nov 01, 2016: Introducing Renishaw's new RA802 Pharmaceutical Analyser
  • 6.14. Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance
  • 6.15. Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results
  • 6.16. Oct 25, 2016: Abaxis Reports Financial Performance For The Second Quarter Of Fiscal 2017
  • 6.17. Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016
  • 6.18. Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results
  • 6.19. Oct 19, 2016: IDEXX Laboratories Elects Lawrence D. Kingsley to Board of Directors
  • 6.20. Oct 18, 2016: Agenix: US sales and key appointment
  • 6.21. Oct 17, 2016: PerkinElmer Elects Samuel Chapin to Board of Directors
  • 6.22. Oct 17, 2016: Thermo Fisher Scientific Enables Preemptive Pharmacogenomic Screening Research with New PharmacoScan Solution
  • 6.23. Oct 17, 2016: New design of hematology and clinical chemistry analyzers
  • 6.24. Oct 14, 2016: Agenix: Appointment of Independent Non- Executive Directors
  • 6.25. Oct 12, 2016: Danaher to Acquire Phenomenex
  • 6.26. Oct 10, 2016: Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2016
  • 6.27. Oct 03, 2016: Boule Diagnostics Raises Funds in Private Placement of Shares
  • 6.28. Sep 26, 2016: PerkinElmer Announces New Organizational Structure
  • 6.29. Sep 24, 2016: Proxima Demonstrated at NVIC Congress Following Significant Sale in Benelux
  • 6.30. Sep 23, 2016: Siegfried Russwurm to resign by mutual agreement from the Siemens Management Board
  • 6.31. Sep 15, 2016: Unique in-line blood gas analyser selected to feature in BACCN annual conference Simulation Lab
  • 6.32. Sep 14, 2016: Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes
  • 6.33. Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories
  • 6.34. Sep 12, 2016: Patient-dedicated blood gas analysis enhances flu readiness and infection control
  • 6.35. Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report
  • 6.36. Sep 07, 2016: Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028
  • 6.37. Sep 07, 2016: Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028
  • 6.38. Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results
  • 6.39. Sep 02, 2016: Danaher Acquires Cepheid
  • 6.40. Aug 31, 2016: bioMerieux - First-Half 2016 Results
  • 6.41. Aug 30, 2016: Sphere Medical expands sales into Belgium
  • 6.42. Aug 30, 2016: AGENIX Announces Annual Result For The Year Ended 30 June 2016
  • 6.43. Aug 19, 2016: Curetis Reports Financial Results for the First Six Months of 2016
  • 6.44. Aug 18, 2016: Thermo Fisher Scientific May Acquire Illumina for USD30 Billion
  • 6.45. Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results
  • 6.46. Aug 11, 2016: Akers Biosciences Announces H1 and Q2 2016 Earnings
  • 6.47. Aug 08, 2016: OPKO Health Reports Improved Financial and Operating Results
  • 6.48. Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results
  • 6.49. Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter
  • 6.50. Aug 04, 2016: PerkinElmer Announces Financial Results for the Second Quarter of 2016
  • 6.51. Aug 04, 2016: Diasorin Group Revenues And EBITDA Reached Record highs In the Second Quarter 2016
  • 6.52. Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results
  • 6.53. Jul 28, 2016: Illumina Names Philip W. Schiller to its Board of Directors
  • 6.54. Jul 28, 2016: Thermo Fisher Scientific Reports Second Quarter 2016 Results
  • 6.55. Jul 28, 2016: QIAGEN Reports Results for Second Quarter of 2016; Increased Commitment to Return $300 Million of Capital to Shareholders by End-2017
  • 6.56. Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors
  • 6.57. Jul 28, 2016: Luminex Reports Second Quarter 2016 Results
  • 6.58. Jul 28, 2016: Cepheid Reports Second Quarter 2016 Results
  • 6.59. Jul 27, 2016: PerkinElmer Elects Frank Witney to Board of Directors
  • 6.60. Jul 26, 2016: Mindray and MedTest announce FDA 510(k) Clearance for the BA-800M Clinical Chemistry Analyzer
  • 6.61. Jul 26, 2016: Illumina Reports Financial Results for Second Quarter of Fiscal Year 2016
  • 6.62. Jul 25, 2016: Abingdon Health announces GMP compliant facilities and registration with U.S. FDA
  • 6.63. Jul 21, 2016: Abaxis Reports Financial Performance for the First Quarter of Fiscal 2017 and Declares a Quarterly Cash Dividend
  • 6.64. Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results
  • 6.65. Jul 19, 2016: MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts
  • 6.66. Jul 18, 2016: bioMerieux - Second-Quarter 2016 Business Review
  • 6.67. Jul 14, 2016: microDimensions Raises Funds in Series A Financing Round
  • 6.68. Jul 12, 2016: PerkinElmer Raises USD552.3 Million in Public Offering of 1.875% Senior Notes Due 2026
  • 6.69. Jul 11, 2016: Abingdon Health Raises USD4 Million in Venture Financing
  • 6.70. Jul 11, 2016: EKF Diagnostics Holdings Appoints Carl Dominic Contadini As Non-Executive Director
  • 6.71. Jul 07, 2016: Enzo Biochem's Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware With Illumina
  • 6.72. Jul 06, 2016: Luminex Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System
  • 6.73. Jul 04, 2016: Exiqon - Nomination of candidates for the supervisory board
  • 6.74. Jul 04, 2016: Curetis Appoints Christopher M. Bernard as Chief Executive Officer of Newly-Formed U.S. Subsidiary
  • 6.75. Jun 30, 2016: Merck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance
  • 6.76. Jun 17, 2016: Daxor Announces Hiring of Chief Financial Officer
  • 6.77. Jun 15, 2016: Siemens Healthcare Becomes Siemens Healthineers
  • 6.78. Jun 14, 2016: Proxima interface to Conworx data management solutions enables seamless data transfer from ex-vivo analyser
  • 6.79. Jun 13, 2016: OPKO Health Announces Move to NASDAQ Stock Market
  • 6.80. Jun 10, 2016: Diadexus to File Chapter 7
  • 6.81. Jun 06, 2016: Curetis and Axonlab sign multi-market European distribution agreement
  • 6.82. Jun 02, 2016: EKF Diagnostics Raises USD7 Million in Private Placement of Shares
  • 6.83. Jun 02, 2016: Illumina Appoints Paula Dowdy Senior Vice President and General Manager of Commercial Operations for Europe, the Middle East and Africa
  • 6.84. May 31, 2016: ERBA Diagnostics Announces Extension of CEO'S Contract Term and Appointment of Hayden Jeffreys to Board of Directors
  • 6.85. May 20, 2016: ERBA Diagnostics Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards and Extension of Compliance Plan
  • 6.86. May 20, 2016: Curetis Publishes First Quarter 2016 Business and Financial Update
  • 6.87. May 12, 2016: Akers Biosciences: Financial Results for the First Quarter 2016
  • 6.88. May 12, 2016: Akers Biosciences Reports Earnings for Q1 2016
  • 6.89. May 12, 2016: Boule Diagnostics Interim report January-March 2016
  • 6.90. May 11, 2016: Clarissa Haller new head of communications at Siemens
  • 6.91. May 10, 2016: Thermo Fisher Scientific Reports Progress on Global Corporate Social Responsibility
  • 6.92. May 09, 2016: EKF Diagnostics Announces Directorate Change
  • 6.93. May 09, 2016: OPKO Health Reports First Quarter Financial and Operating Results
  • 6.94. May 04, 2016: Earnings Release and Financial Results Q2 FY 2016: Continuing growth in orders, revenue and profitability
  • 6.95. Apr 20, 2016: Abbott Reports First-Quarter 2016 Results
  • 6.96. Apr 20, 2016: EKF Diagnostics Holdings Announces Directorate Change
  • 6.97. Apr 18, 2016: NanoIVD Announces 510(k) Pre-Sub Supplement on PanOnco Check
  • 6.98. Apr 12, 2016: EKF Diagnostics Holdings: Final results
  • 6.99. Apr 07, 2016: Luminex to Showcase CE-IVD Marked ARIES System, Revolutionary Software, and Assays at ECCMID Annual Meeting
  • 6.100. Mar 23, 2016: STRATEC Biomedical to Acquire Diatron from Riverside Company
  • 6.101. Mar 16, 2016: New Luna Omega 1.6 Micron Particle Brings Acclaimed Capabilities to UHPLC
  • 6.102. Mar 14, 2016: Instrumentation Laboratory Reports Record Worldwide Sales In 2015
  • 6.103. Mar 01, 2016: HORIBA: Alliance'2016
  • 6.104. Feb 23, 2016: Thermo Fisher Scientific Exhibits ClinQuan MD Software for In Vitro Diagnostic Use at MSACL 2016
  • 6.105. Feb 18, 2016: Boule Diagnostics: Year-end report 2015
  • 6.106. Feb 12, 2016: DiaSys Diagnostic Systems presents QDx Lipidcheck at Arab Health in January 2016
  • 6.107. Feb 09, 2016: HORIBA Formulates New Mid-Long Term Management Plan MLMAP2020
  • 6.108. Feb 02, 2016: Life Line Screening Enters Into Multi-Year Contract Extension for CardioChek Family of Lipid and Glucose Products
  • 6.109. Jan 29, 2016: IDEXX Laboratories Announces Fourth Quarter and Full Year 2015 Results
  • 6.110. Jan 26, 2016: Sphere Medical Holding: Contract Win
  • 6.111. Jan 26, 2016: Premaitha Health: Update on UK Litigation Timing
  • 6.112. Jan 20, 2016: EKF Diagnostics highlight new clinical chemistry analyzer at Arab Health 2016
  • 6.113. Dec 03, 2015: Patient-dedicated blood gas analyser for use in winter flu isolation beds

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Clinical Chemistry Analyzers - Pipeline Products by Stage of Development
  • Table 2: Clinical Chemistry Analyzers - Pipeline Products by Segment
  • Table 3: Clinical Chemistry Analyzers - Pipeline Products by Territory
  • Table 4: Clinical Chemistry Analyzers - Pipeline Products by Regulatory Path
  • Table 5: Clinical Chemistry Analyzers - Pipeline Products by Estimated Approval Date
  • Table 6: Clinical Chemistry Analyzers Companies - Pipeline Products by Stage of Development
  • Table 7: Clinical Chemistry Analyzers - Pipeline Products by Stage of Development
  • Table 8: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Biolyzer 100 - Product Status
  • Table 10: Biolyzer 100 - Product Description
  • Table 11: Biolyzer 300 - Product Status
  • Table 12: Biolyzer 300 - Product Description
  • Table 13: Biolyzer 600 - Product Status
  • Table 14: Biolyzer 600 - Product Description
  • Table 15: Ativa Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Ativa Micro-Lab System - Product Status
  • Table 17: Ativa Micro-Lab System - Product Description
  • Table 18: Aviv Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Bili-4 Hematofluorometer - Product Status
  • Table 20: Bili-4 Hematofluorometer - Product Description
  • Table 21: Beacon Biotechnology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: BrightSPOT - Product Status
  • Table 23: BrightSPOT - Product Description
  • Table 24: Curetis N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: Unyvero Analyzer - Product Status
  • Table 26: Unyvero Analyzer - Product Description
  • Table 27: Daxor Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Total Blood Volume Analyzer - Total Body Albumin - Product Status
  • Table 29: Total Blood Volume Analyzer - Total Body Albumin - Product Description
  • Table 30: DiaSys Diagnostic Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: QDx Lipidcheck - Product Status
  • Table 32: QDx Lipidcheck - Product Description
  • Table 33: respons940 - Product Status
  • Table 34: respons940 - Product Description
  • Table 35: EMERGENT DETECTION INC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: BodyKey Fat Loss Sensor - Product Status
  • Table 37: BodyKey Fat Loss Sensor - Product Description
  • Table 38: Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Paper-Based Microfluidic Analytical System - Product Status
  • Table 40: Paper-Based Microfluidic Analytical System - Product Description
  • Table 41: Illumina, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: LSD-100 Lysosomal Storage Enzyme Analyzer - Product Status
  • Table 43: LSD-100 Lysosomal Storage Enzyme Analyzer - Product Description
  • Table 44: Intelligent Fingerprinting Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: Intelligent Fingerprinting - Product Status
  • Table 46: Intelligent Fingerprinting - Product Description
  • Table 47: I-Sens Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Blood Gas Analyzer - Product Status
  • Table 49: Blood Gas Analyzer - Product Description
  • Table 50: MyCartis NV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Evalution - Product Status
  • Table 52: Evalution - Product Description
  • Table 53: NanoIVD Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: NanoIVD Clinical Analyzer-I - Product Status
  • Table 55: NanoIVD Clinical Analyzer-I - Product Description
  • Table 56: National Institute of Biomedical Imaging and Bioengineering Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Microfluidic Diagnostic Card - Product Status
  • Table 58: Microfluidic Diagnostic Card - Product Description
  • Table 59: NeuMoDx Molecular, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: NeuMoDx 500 Molecular IVD System - Product Status
  • Table 61: NeuMoDx 500 Molecular IVD System - Product Description
  • Table 62: OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 63: Claros 1 Analyzer - Product Status
  • Table 64: Claros 1 Analyzer - Product Description
  • Table 65: OptiCul Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: Optidet Multi - Product Status
  • Table 67: Optidet Multi - Product Description
  • Table 68: Renishaw Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: RenDx Multiplex Assay System - Product Status
  • Table 70: RenDx Multiplex Assay System - Product Description
  • Table 71: Rheonix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 72: EncompassMDx Platform - Product Status
  • Table 73: EncompassMDx Platform - Product Description
  • Table 74: Samsung Electronics Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 75: LABGEO PT10 - Product Status
  • Table 76: LABGEO PT10 - Product Description
  • Table 77: Sekisui Diagnostics, LLC. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 78: SK500 Clinical Chemistry System - Product Status
  • Table 79: SK500 Clinical Chemistry System - Product Description
  • Table 80: Smiths Detection Group Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 81: Bio-Seeq - Clinical - Product Status
  • Table 82: Bio-Seeq - Clinical - Product Description
  • Table 83: The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 84: Portable Real-time PCR System - Product Status
  • Table 85: Portable Real-time PCR System - Product Description
  • Table 86: Theranos Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: miniLab System - Product Status
  • Table 88: miniLab System - Product Description
  • Table 89: Thermal Gradient, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: Flash HT - Product Status
  • Table 91: Flash HT - Product Description
  • Table 92: Glossary

List of Figures

  • Figure 1: Clinical Chemistry Analyzers - Pipeline Products by Stage of Development
  • Figure 2: Clinical Chemistry Analyzers - Pipeline Products by Segment
  • Figure 3: Clinical Chemistry Analyzers - Pipeline Products by Territory
  • Figure 4: Clinical Chemistry Analyzers - Pipeline Products by Regulatory Path
  • Figure 5: Clinical Chemistry Analyzers - Pipeline Products by Estimated Approval Date
Back to Top